Myt-healer: a new potent wound healing peptide

Patent number:

WO20109642

No items found.

The present invention relates to peptides derived from myticin C and to their therapeutic use, more specifically in cell and/or tissue regeneration.

Countries:

Spain

Regions:

Valencian Community

Centers:

CSIC, UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Other entities:

Sectors:

Health

Subsectors:

Pharmaceuticals, Biotechnology

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

- Myt-healer is a short peptide, easy to synthesize - Myt-healer can be used both in aqueous solutions or as a part of a releasing device. - Myt-healer activity is retained in the presence of serum components. - Myt-healer shows a strong wound healing: 5 μM Myt-healer seals the induced injury in HaCaT (Culture Human Keratinocyte) monolayer in 24 h.

Comments

Other related patents

Health

METHOD TO ENHANCE OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STROMAL CELLS

Countries

Spain

Health

DIFLUOROBENZYL ETHANOLAMINE DERIVATIVES WITH ANTIMICROBIAL ACTIVITY

Countries

Spain

Health

NUTRITIONAL PREPARATION AS PREVENTATIVE OF PRE AND POST-PARTUM DEPRESSION

Countries

Spain

Get back to patents directory